Hemofarm

Manufacturing high quality, effective, safe and affordable pharmaceutical products is the core activity of the company. Since 2006, Hemofarm has been a part of the German STADA Group, one of the largest generic pharmaceutical companies in the world.

Leading Position

Hemofarm is the leader on the pharmaceutical market of Serbia. Taking up over 70% of the total exports of pharmaceutical products, the Vršac-based company is at the same time the largest Serbian exporter of drugs. Hemofarm manufactures about 6.6 billion tablets and capsules annually. It operates on four continents and it has a team of over 3,600 employees. In addition to being present on 34 markets around the World, Hemofarm is among the largest pharmaceutical manufacturers in this region.

The company is committed to permanent innovation. In addition to researching and developing modern pharmaceutical products, Hemofarm pays special attention to sustainable. It is in compliance with the BSCI Code of social responsibility and respect for human rights, with one of the highest degrees of compliance of all the companies operating in Serbia.

Seat and Representative Offices

In addition to its headquarters in Vršac, Hemofarm has registered representative offices in Belgrade, Niš, Novi Sad, and Kragujevac. Šabac is the seat of the subsidiary company that became a part of Hemofarm A.D. through an acquisition in January 2015.

Apart from Serbia, Hemofarm also has subsidiaries in the region – in Macedonia, Bosnia and Herzegovina, Montenegro, and Romania. Apart from the subsidiary in Romania, there is also a Hemofarm’s European laboratory in Timisoara.

See the list of represntative offices